PIPA520895

CALHM1 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA520895-Each-of-1 In Stock ₹ 46,502.50

PIPA520895 - Each of 1

₹ 46,502.50

In Stock

Quantity

1

Base Price: ₹ 46,502.50

GST (18%): ₹ 8,370.45

Total Price: ₹ 54,872.95

Antigen

CALHM1

Classification

Polyclonal

Conjugate

Unconjugated

Gene

Calhm1

Gene Alias

calcium homeostasis modulator 1; calcium homeostasis modulator protein 1; Calhm1; EG546729; Fam26c; family with sequence similarity 26, member C; Protein FAM26C; RGD1564891

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

255022, 499367, 546729

Content And Storage

Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C

Form

Liquid

Applications

Immunohistochemistry, Western Blot

Concentration

1 mg/mL

Formulation

PBS with 0.02% sodium azide

Gene Accession No.

D3Z291, Q8IU99

Gene Symbols

Calhm1

Immunogen

A 17 amino acid peptide near the amino terminus of human CALHM1.

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human, Mouse, Rat

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA520983

--

Img

Thermo Scientific

PIPA520760

--

Img

Thermo Scientific

PIPA520931

--

Img

Thermo Scientific

PIPA521164

--

Img

Thermo Scientific

PIPA521078

--

Img

Thermo Scientific

PIPA521058

--

Img

Thermo Scientific

PIPA520735

--

Img

Thermo Scientific

PIPA520920

--

Description

  • A suggested positive control is rat liver tissue lysate
  • PA5-20895 can be used with blocking peptide PEP-1009
  • Alzheimers disease (AD) is a progressive neurodegenerative disorder characterized by a massive loss of neurons in several brain regions and by the presence of senile plaques comprised of aggregated amyloid-beta (Abeta) peptides produced by the endoproteolysis of the amyloid precursor protein (APP)
  • The calcium homeostasis modulator 1 (CALHM1) is a recently identified multipass transmembrane glycoprotein that controls cytosolic Ca2+ concentration and Abeta levels
  • While some studies suggest CALHM1 is significantly associated with risk of AD, other reports suggest there is no link
  • CALHM1 has been suggested to modulate the Ca2+-dependent proteolytic process of APP through controlling the level of cytosolic Ca2+.